05/02/2024 11:15 PM | Vaxxinity (Filer)
| Form EFFECT | |
04/30/2024 3:46 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/30/2024 3:35 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/29/2024 4:06 PM | Vaxxinity (Filer)
| Form 10-K/A | |
04/29/2024 3:46 PM | Vaxxinity (Filer)
| Form PRE 14C | |
03/27/2024 3:18 PM | Vaxxinity (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 3:15 PM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
01/30/2024 3:04 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 9:30 AM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 4:03 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 4:13 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 4:10 PM | Prime Movers Growth GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023 3:20 PM | Prime Movers Growth GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023 3:21 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 6:53 AM | Vaxxinity (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023 3:31 PM | Paula Molina Rene (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 8:42 PM | Powchik Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 8:40 PM | Ray Sumita (Reporting) Vaxxinity (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2023 3:33 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/28/2023 3:15 PM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 3:12 PM | Prime Movers Growth GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023 3:16 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:10 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:11 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:14 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:18 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:19 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:34 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:24 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:26 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:31 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:18 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:32 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:00 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:01 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:02 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 4:02 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 4:12 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 4:20 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 3:52 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 3:42 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Gold Set to EXPLODE! (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
09/08/2023 5:05 PM | Prime Movers Lab Fund I LP (Reporting) Sloss Dakin (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 4:33 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 4:14 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 4:23 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 3:50 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:38 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:42 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:26 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:32 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:20 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:13 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:14 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:15 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:16 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:18 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2023 11:15 PM | Vaxxinity (Filer)
| Form EFFECT | |
08/09/2023 6:30 AM | Vaxxinity (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023 6:31 AM | Vaxxinity (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/26/2023 5:31 PM | Powchik Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:32 PM | Diamandis Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:34 PM | TOLEDANO GABRIELLE B (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:35 PM | Eade Katherine A. (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:37 PM | Ogilvie Landon E (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:37 PM | Smith James Alan (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:39 PM | HORNIG GEORGE R (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:30 PM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2023 6:00 AM | Vaxxinity (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |